These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 35695727)
1. Specific Peptide from the Novel W-Tau Isoform Inhibits Tau and Amyloid β Peptide Aggregation Cuadros R; Pérez M; Ruiz-Gabarre D; Hernández F; García-Escudero V; Avila J ACS Chem Neurosci; 2022 Jul; 13(13):1974-1978. PubMed ID: 35695727 [TBL] [Abstract][Full Text] [Related]
2. Interplay of isoform 1N4R tau protein and amyloid-β peptide fragment 25-35 in reducing and non-reducing conditions. Mohammadi F; Takalloo Z; Rahmani H; Nasiri Khalili MA; Khajeh K; Riazi G; H Sajedi R J Biochem; 2021 Feb; 169(1):119-134. PubMed ID: 32857841 [TBL] [Abstract][Full Text] [Related]
3. Assessment of Amyloid Forming Tendency of Peptide Sequences from Amyloid Beta and Tau Proteins Using Force-Field, Semi-Empirical, and Density Functional Theory Calculations. Muvva C; Murugan NA; Subramanian V Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806726 [TBL] [Abstract][Full Text] [Related]
4. Dependence of the Formation of Tau and Aβ Peptide Mixed Aggregates on the Secondary Structure of the N-Terminal Region of Aβ. Rojas AV; Maisuradze GG; Scheraga HA J Phys Chem B; 2018 Jul; 122(28):7049-7056. PubMed ID: 29940109 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the Aggregation and Toxicity of the Minimal Amyloidogenic Fragment of Tau by Its Pro-Substituted Analogues. Chemerovski-Glikman M; Frenkel-Pinter M; Mdah R; Abu-Mokh A; Gazit E; Segal D Chemistry; 2017 Jul; 23(40):9618-9624. PubMed ID: 28544138 [TBL] [Abstract][Full Text] [Related]
6. Design of amyloidogenic peptide traps. Sahtoe DD; Andrzejewska EA; Han HL; Rennella E; Schneider MM; Meisl G; Ahlrichs M; Decarreau J; Nguyen H; Kang A; Levine P; Lamb M; Li X; Bera AK; Kay LE; Knowles TPJ; Baker D Nat Chem Biol; 2024 Aug; 20(8):981-990. PubMed ID: 38503834 [TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into remodeled Tau-derived PHF6 peptide fibrils by Naphthoquinone-Tryptophan hybrids. KrishnaKumar VG; Paul A; Gazit E; Segal D Sci Rep; 2018 Jan; 8(1):71. PubMed ID: 29311706 [TBL] [Abstract][Full Text] [Related]
8. The role of anionic peptide fragments in 1N4R human tau protein aggregation. Khalili MA; Riazi G; Ahmadian S; Khodarahmi R; Khodadadi S; Afrasiabi A; Karima O; Mokhtari F; Hoveizi E Protein Pept Lett; 2014 Jun; 21(6):511-6. PubMed ID: 24364857 [TBL] [Abstract][Full Text] [Related]
9. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system. Tackenberg C; Kulic L; Nitsch RM PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331 [TBL] [Abstract][Full Text] [Related]
10. Hsp70 alters tau function and aggregation in an isoform specific manner. Voss K; Combs B; Patterson KR; Binder LI; Gamblin TC Biochemistry; 2012 Jan; 51(4):888-98. PubMed ID: 22236337 [TBL] [Abstract][Full Text] [Related]
11. Intrinsic Origin of Amyloid Aggregation: Collective Effects of the Mutation and Tautomerism of Histidine. Li H; Salimi A; Lee JY ACS Chem Neurosci; 2019 Nov; 10(11):4729-4734. PubMed ID: 31600048 [TBL] [Abstract][Full Text] [Related]
12. Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II. Rank KB; Pauley AM; Bhattacharya K; Wang Z; Evans DB; Fleck TJ; Johnston JA; Sharma SK FEBS Lett; 2002 Mar; 514(2-3):263-8. PubMed ID: 11943163 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 1,2,3,4-tetrahydro-1-acridone analogues as potential dual inhibitors for amyloid-beta and tau aggregation. Lv P; Xia CL; Wang N; Liu ZQ; Huang ZS; Huang SL Bioorg Med Chem; 2018 Sep; 26(16):4693-4705. PubMed ID: 30107970 [TBL] [Abstract][Full Text] [Related]
15. Near-Wall Aggregation of Amyloidogenic Aβ 1-40 Peptide: Direct Observation by the FRET. Katina N; Mikhaylina A; Ilina N; Eliseeva I; Balobanov V Molecules; 2021 Dec; 26(24):. PubMed ID: 34946672 [TBL] [Abstract][Full Text] [Related]
16. Measurement of intrinsic properties of amyloid fibrils by the peak force QNM method. Adamcik J; Lara C; Usov I; Jeong JS; Ruggeri FS; Dietler G; Lashuel HA; Hamley IW; Mezzenga R Nanoscale; 2012 Aug; 4(15):4426-9. PubMed ID: 22688679 [TBL] [Abstract][Full Text] [Related]
17. Catalytic Prion-Like Cross-Talk between a Key Alzheimer's Disease Tau-Fragment R3 and the Type 2 Diabetes Peptide IAPP. Arya S; Claud SL; Cantrell KL; Bowers MT ACS Chem Neurosci; 2019 Nov; 10(11):4757-4765. PubMed ID: 31642657 [TBL] [Abstract][Full Text] [Related]
18. Development of dual targeting inhibitors against aggregations of amyloid-β and tau protein. Fuse S; Matsumura K; Fujita Y; Sugimoto H; Takahashi T Eur J Med Chem; 2014 Oct; 85():228-34. PubMed ID: 25086914 [TBL] [Abstract][Full Text] [Related]